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Abstract
Background: Neurofibromatosis type1 (NF1) is associated with a broad range of behavioural deficits, and an imbalance
between excitatory and inhibitory neurotransmission has been postulated in this disorder. Inhibition is involved in the
control of frequency and stability of motor rhythms. Therefore, we aimed to explore the link between behavioural motor
control, brain rhythms and brain activity, as assessed by EEG and fMRI in NF1.
Methods: We studied a cohort of 21 participants with NF1 and 20 age- and gender-matched healthy controls, with a
finger-tapping task requiring pacing at distinct frequencies during EEG and fMRI scans.
Results: We found that task performance was significantly different between NF1 and controls, the latter showing higher
tapping time precision. The time-frequency patterns at the beta sub-band (20–26 Hz) mirrored the behavioural
modulations, with similar cyclic synchronization/desynchronization patterns for both groups. fMRI results showed
a higher recruitment of the extrapyramidal motor system (putamen, cerebellum and red nucleus) in the control
group during the fastest pacing condition.
Conclusions: The present study demonstrated impaired precision in rhythmic pacing behaviour in NF1 as compared
with controls. We found a decreased recruitment of the cerebellum, a structure where inhibitory interneurons are
essential regulators of rhythmic synchronization, and in deep brain regions pivotally involved in motor pacing. Our
findings shed light into the neural underpinnings of motor timing deficits in NF1.
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Background
Neurofibromatosis type 1 (NF1) is the most common
autosomal dominant neurogenetic condition with an
estimated prevalence of 1 in 3000 individuals [1–3]. The
disorder is caused by mutations in the NF1 gene that
encodes neurofibromin. This protein is involved in cell
proliferation and differentiation [4], and its loss may
explain abnormalities in the brain structure, which
include increased volume of the cortical and subcortical
structures, and white and gray matter abnormalities [5–9].
Behavioural difficulties are also frequent and encompass a
wide range of cognitive deficits, which include perceptual
impairments, attention and learning disabilities [10–12].
Moreover, there is a tendency for those symptoms to per-
sist or even increase in severity with age [2].
Motor skill and time perception impairments have
been reported in NF1 children [13]. Debrabant and
colleagues [14] studied temporal perception (motor
timing indexed by the reaction time decrease upon
presentation of predictable stimuli). They found that the
clinical group responded with an increased reaction time
to such temporally predictable stimuli (as defined by
regular interstimulus intervals) when compared to
typically developing children [14]. Accordingly, a com-
prehensive study by Hyman on motor and cognitive
function in NF1 showed that fine motor coordination
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deficits and slowing of motor speed were present in
approximately 20 and 30% of the NF1 cohort, respect-
ively [10]. Using a more broad motor performance test
battery, Rietman and colleagues found that 61% of the
studied cohort had motor problems [15].
Although knowledge on the cognitive and behavioural
deficits in NF1 is increasing, the neural mechanisms
underlying such impairments are still poorly understood.
Previous studies addressing other cognitive domains
have proposed that abnormalities in the balance of the
excitatory and the inhibitory activity underlie a basic dis-
ease mechanism.
Initial studies in mouse models of NF1 indicated that
lack of neurofibromin causes increased GABA (γ-amino-
butyric acid)-mediated neurotransmission and showed a
relationship between enhanced inhibitory activity and
behavioural profile [16–18]. However, studies in human
patients have shown a pattern of GABA alterations that
include reduced GABA levels and GABAA receptor
density [19–21]. In order to reconcile these differences
across species, a recent study investigated pre- and post-
synaptic GABA levels in an NF1 mouse model employ-
ing magnetic resonance spectroscopy (the only tech-
nique available to measure GABA levels in vivo in
humans) combined with molecular approaches [22].
This study showed that the pattern of GABA alterations
in mice is region specific and that this pattern is not
always consistent across species. Thus, although muta-
tions in the NF1 gene do seem to impact the GABA
system and those can have behavioural and cognitive
consequences [21], their pattern across species and brain
regions do not seem to be trivial. Importantly, lower
GABA levels may still be consistent with enhanced
inhibitory activity. This is the case for example in the
hippocampus, where low GABA levels coexist with very
high post-synaptic receptor density [22] and increased
inhibitory post-synaptic potentials [18].
Here, we hypothesized that rhythmic taping perform-
ance is impaired in NF1 and that it is related to abnor-
mal physiology and brain activity patterns. Inhibition is
involved in the function of motor central pattern genera-
tors—neuronal circuits that when activated can produce
rhythmic motor patterns [23]—and in the control of
frequency and stability of motor rhythms [24, 25]. We
therefore aimed to explore the link between behavioural
control of motor rhythms, brain oscillations and brain
activity in regions involved in motor pacing. To reach
that goal, we choose a finger-tapping task so we can pre-
cisely measure the participant’s performance either dur-
ing functional magnetic resonance imaging (fMRI) or
electroencephalography (EEG). We used synchronous and
asynchronous finger-tapping tasks. The latter requires
alternated finger tapping, which implies interhemispheric
inhibitory control, in contrast with the synchronous
variant. In both synchronous and asynchronous condi-
tions, finger tapping was performed in incremental rates,
1, 3 and 5 Hz, to vary the performance load. The latter
frequency has been shown to be the most discriminative
of disease states in cerebellar disorders (in particular
genetic ataxias) where rhythmic motor control is impaired
[26]. We hypothesized that the NF1 cohort would perform
worse at rhythmic pacing than the healthy group, and we
aimed to identify the neural correlates of such impaired
temporal patterning. Since oscillatory pacing can be
related to the modulation of populations of inhibitory
interneurons [27, 28], we expected that behavioural differ-
ences would be reflected in the power of the beta band.
We used the same pacing paradigm during functional
scans to induce effects in the BOLD (blood-oxygen-level
dependent) signal in motor-related areas during task per-
formance. We aimed to unravel the neural underpinnings
of abnormal motor coordination.
Methods
Subjects
Twenty-one adults with NF1 were recruited from a data-
base used in previous studies [19] and in collaboration with
the Portuguese Association of Neurofibromatosis. They all
had a definite diagnosis of NF1 in accordance with the cri-
teria of the National Institutes of Health (National Institutes
of Health Consensus Development Conference, 1988). The
control group (20 age- and gender-matched participants)
was recruited via advertisement in the local community.
Exclusion criteria for all participants included psychiatric
disorders, neurologic illness affecting brain function other
than NF1, brain tumor burden, intelligence quotient (IQ)
lower than 75, epilepsy and traumatic brain injury. One
control was excluded due to neurological illness. None of
the NF1 patients were diagnosed with ADHD or had a
formal diagnosis of learning disabilities. None of the partici-
pants were taking medication for treating anxiety or de-
pression in the year before the study, and none of them
were ever medicated with anticonvulsants.
All the participants but one were right-handed as
assessed by the Edinburgh Handedness Inventory [29] and
had normal or corrected to normal visual acuity. Intellec-
tual function was assessed by using the Portuguese-adapted
version of the Wechsler Adult Intelligence Scale-3rd edition
(WAIS-III) [30]. Two control participants were unavailable
to complete the IQ assessment. Full-scale IQ values were in
the normal range for the NF1 patients (mean IQ ± SD 104.
4 ± 13.7). All the participants performed the standard
Stroop Colour and Word Test [31] composed by two con-
gruent conditions [word (W) and colour (C)] and one
incongruent (interference) condition [colour-word (CW)].
Participants had 45 s to complete each task condition. An
Interference Index was calculated according to the method
proposed by Golden [31]: incongruent score (IG) = CW
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− [(W ×C)/(W+C)]. Groups did not differ regarding this
index (independent-samples t tests, p > .05), indicating
similar ability to control over the interference effect.
Three participants were excluded from the EEG analysis.
One due to a malfunction in the trigger recording system
and two due to differences in the cap system (ground
positioning and channel locations). Two participants
exceeded the limits of movement during the functional
magnetic resonance (3 mm in, at least, one axis), and thus
were excluded from that analysis. Our final sample for the
EEG analysis was composed of 19 patients with NF1 and
19 controls. The clinical group (n = 19, 10 females, age
range 23.8–51.8, mean age ± standard deviation [SD] 36.1
± 6.7) and the control group (n = 19, 11 females, age range
22.5–55.0, mean age ± SD 37.1 ± 7.2) were matched for
age (U = 160.0, p = 0.549) and gender (χ2 (1) = .106, p = 0.
744). The final sample for the fMRI analysis was
composed of 19 patients with NF1 and 20 controls. The
clinical group (n = 19, 11 females, age range 23.8–51.8,
mean age ± standard deviation [SD] 36.5 ± 7.0) and the
control group (n = 20, 12 females, age range 22.5–55.0,
mean age ± SD 36.8 ± 7.1) were matched for age (U = 182.
5, p = 0.833) and gender (χ2 (1) = .018, p = 0.894).
Task
Participants performed a previously validated audio-paced
tapping paradigm [26] at three incremental frequencies (1,
3 and 5 Hz). Participants were asked to tap using both
index fingers either simultaneously (“synchronous” condi-
tion) or alternating the tapping (“alternating” or “asyn-
chronous” condition) as prompted by a cue shown in a
computer screen (“A” for the alternating condition and an
“S” for the synchronous condition). All participants were
familiarized with the task and the interface before the
beginning of the recording sessions. The paradigm was
designed and presented using the Psychophysics Toolbox
3 [32, 33], running on Matlab R2013b (MathWorks,
Natick, MA, USA).
For the fMRI task, a total of 24 blocks of the motor
paradigm, 8 per frequency (4 synchronous and 4 alter-
nating), were presented. Block duration was 9 s either
for the finger tapping or for the baseline. The cues were
presented in a 698.40 × 392.85 mm LCD monitor (Nor-
dicNeuroLab, Bergen, Norway), placed ~ 156 cm away
from the participants’ head. Audio was provided through
MR-compatible headphones. Behavioural data (tapping
timings) were recorded using the MRI-compatible re-
sponse box Lumina LP-400 (Cedrus Corporation, San
Pedro, CA, USA).
Regarding the EEG acquisition, we acquired four runs,
each composed of five repetitions of the main sequence
(1, 3 and 5 Hz, each frequency executed in two variations,
synchronous and alternating). Blocks lasted 12 s and were
composed by a baseline period of 3 s (where the partici-
pant fixated the central cross and did not execute any
movements) and 9 s of task (see Fig. 1). The cueing
Fig. 1 Experimental design of the behavioural task during the EEG task (concerning the fMRI design, see text). The participants were instructed to
make an audio-paced tapping using both index fingers, synchronously or alternately, as indicated by the visual cue. The tapping frequency was
set at 1, 3 or 5 Hz, and it was set by a beep
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paradigm was presented in a laptop placed ~ 50 cm in
front of the participant. Participants were instructed to
fixate the centre of the screen during the EEG task, and
behavioural data were recorded using the “Z” and “M”
buttons of a common keyboard.
MR recordings and analysis
MR scans were acquired in a 3T Magnetom Tim Trio
scanner (Siemens, Erlangen, Germany), using a 12-
channel birdcage head coil. A T1-weighted magnetization-
prepared rapid gradient echo sequence was acquired with
a repetition time of 2530 ms, echo time of 3.42 ms, reso-
lution of 1 mm3 isotropic voxel, flip angle of 7°, matrix
size 256 × 256 and a field of view of 256 × 256 mm.
Functional data were acquired using echo-planar imaging
sequences, using voxel size 3 mm2 and slice thickness of
3 mm, no gap between slices, 43 slices acquired parallel to
the anterior commissure-posterior commissure line, repe-
tition time 3000 ms, echo time 30 ms, flip angle of 90°,
matrix size 256 × 256 and a field of view of 256 × 256 mm.
In total, 147 volumes were acquired. A T2-weighted fluid
attenuation inversion recovery sequence was used to iden-
tify unidentified bright objects, and it was acquired using
a 1 mm3 voxel, repetition time 5 s, echo time 388 ms,
inversion time 1.8 s, field of view 250 × 250 mm, matrix
size 256 × 256 and160 slices.
The complete processing pipeline and analysis of the
functional data was done using BrainVoyager QX 2.8.2
(Brain Innovation, Maastricht, The Netherlands). Data
were corrected for (1) slice scanning time differences
using cubic spline interpolation, (2) motion artifacts by
combining trilinear and sinc function based methods
for interpolation in the three axes and (3) filtered in the
time domain using an approach with Fourier basis set
using 2 cycles per time course. Functional data were
automatically co-registered to the anatomical T1 (and
manually verified) and subsequently normalized to the
Talairach atlas. Spatial smoothing was applied using a
Gaussian kernel with a full width at half maximum of
6 mm. Statistical analyses were performed at the group
level using a general linear model approach. The pre-
dictor’s model was obtained by convolution of the box-
car function with a standard 2-gamma hemodynamic
response function. Motion parameters were also in-
cluded in the model as regressors of no interest. Ran-
dom effects analysis (RFX) was performed, and the
results were corrected for multiple comparisons using
false discovery rate (FDR) with a fixed p value of 0.05
and minimum cluster extension of 20 voxels.
EEG recordings and analysis
Electroencephalographic signals were recorded using a
64 electrodes cap (QuickCap, NeuroScan, USA) with
electrodes placed according to the extended 10/20
system. In order to ensure the quality of the signal, all
electrode impedances were kept below 20 kΩ. The con-
tinuous signal was amplified and recorded at a sampling
rate of 1 kHz, low pass filter at 200 Hz, through a
SynAmps2/RT amplifier. Data were acquired using Scan
4.5 (NeuroScan, Compumedics, Charlotte, NC), and the
acquisition reference was set to an electrode located at a
half distance between CZ and FCZ.
The processing was performed using the EEGlab tool-
box [34] for Matlab (MathWorks, Natick, MA). The
EEG signal was downsampled to 400 Hz and digitally
filtered between 1 and 100 Hz. A notch filter (47.5–52.
5 Hz) was applied, and epochs from − 3000 to 9000 ms
were obtained locked to the stimuli onset. Epoch rejec-
tion was done automatically by scanning the entire data-
set using a rejection threshold of 120 μV for all
electrodes followed by visual inspection to ensure the
data was free from artifacts. Channels with abnormal
noise activity were interpolated using spherical spline
interpolation. The HEO/VEO channels were excluded
from further analysis, and the recordings were re-
referenced to the average of all remaining channels. We
proceeded to epoch division by trigger data, i.e. we sepa-
rated the time-frequency epochs by sub-task type (1, 3
and 5 Hz tapping, synchronous and alternated). All the
participants met the minimum criterion (more than
40%) of the trials per condition available for analysis.
Time-frequency decomposition was done using the
function pop_newtimef(), with Morlet wavelet, beginning
with a 7-cycle at 6 Hz and increasing linearly with fre-
quency (maximum of 30 cycles at 50 Hz). We calculated
400 timepoints (with an effective time window from −
2600 to 6080 ms) and set the baseline from the begin-
ning of the epoch until 100 ms before the onset of the
stimulus. Electrodes corresponding to motor areas were
clustered (FC1, FC2, CZ, C1, C3, C2 and C4). We trun-
cated the time analysis intervals (from − 2000 to
6000 ms) in order to avoid boundary effects on time-
frequency spectra.
Further analysis was performed in the time-course
variation for three sub-bands of mu, beta and gamma
frequencies (respectively, 8–12, 20–26 and 40–44 Hz
intervals). Beta range (20–26 Hz range) was defined
around the desynchronization peak that matches the
motor pattern. The choice of the interval of low
gamma was based on our previous work [35–37] and
was set up to 44 Hz to avoid power line interferences
in the time-frequency analysis. The bands were not
juxtaposed, in order to avoid information contamin-
ation between bands. Frequency-domain evaluations
were performed specifically for beta sub-band varia-
tions, since they exhibit a marked sinusoidal profile,
matching motor responses. For that, we computed
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the power per subject at the exact frequency of
tapping.
Statistics for group comparisons
Measurements of motor performance were done in data
recorded during EEG recordings because larger amounts
of data could be recorded. The statistical comparison
between groups was performed using one-way multivari-
ate ANOVAs (MANOVAs) to determine whether there
are any differences between the independent variable
(group) based on the dependent continuous variables
(tapping at three different frequencies: 1, 3 and 5 Hz), for
synchronous and asynchronous conditions. Similarly,
we used MANOVA to test group differences on EEG
data.
Results
Behavioural results
Tapping time histograms reflecting the distribution of
motor responses in the synchronous condition are pre-
sented in Fig. 2. The histograms indicate a reduction in
tapping time precision in patients with NF1 compared
to the healthy control group as indexed by the sharper
curve around the cued tapping time in the control
group. To quantify this effect, we computed the power
at the ideal tapping frequency as a measure of motor
performance precision. Higher power values correspond
Fig. 2 a Tapping time histograms (relative tapping frequency) for the synchronous condition. b Power at the ideal (cues) tapping frequency for
controls and NF1 for the synchronous (S) and alternating (A) conditions. Healthy controls (green) performed better than participants with NF1
(red) at all the conditions, except the 5 Hz condition. The horizontal lines indicate the mean and standard deviation
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to higher participant’s ability to keep tapping at the re-
quired frequency.
For the synchronous condition, we found, as assessed by
MANOVA, a statistically significant difference between
controls and NF1 patients, F (3, 34) = 6.10, p = 0.041; Wilk’s
Λ = 0.787. These differences in behavioural performance
were significant at all tested frequencies of 1, 3 and 5 Hz
(respectively, F (1, 36) = 7.14, p = 0.011; F (1, 36) = 6.61, p =
0.014; and F (1, 36) = 4.887, p < 0.034).
For the asynchronous condition, MANOVA also yielded
statistically significant differences between groups, F (3,34)
= 6.104, p = 0.02; Wilk’s Λ = 0.650. Subsequent analyses
revealed that these effects were mainly derived from differ-
ences at 1 and 3 Hz (respectively, F (1, 36) = 9.84, p = 0.003
and F (1, 36) = 17.01, p < 0.001).
We followed up this analysis by performing ROC (re-
ceiver operating characteristic) curve analysis to further
investigate which frequencies better discriminated be-
tween patients (n = 18) and controls (n = 19), Fig. 3.
Synchronous 1 Hz tapping and alternated 3 Hz tapping
were the most suitable to separate patients with NF1
from controls (respectively, area ± standard deviation 0.
7729 ± 0.0781, p = 0.012 and 0.8421 ± 0.0622, p < 0.01,
corrected for multiple comparisons), such that the
alternated test at 3 Hz achieved a sensitivity of 84%
with 74% specificity.
EEG results
Time-frequency analysis in the motor cluster (electrodes
FC1, FC2, CZ, C1, C3, C2 and C4) was performed for both
groups. Plots for the synchronous condition at 1 Hz are
presented in Fig. 4. Both groups exhibit a marked cyclic
synchronization/desynchronization pattern in the mu and
beta range, which are known to be tightly related with the
behavioural execution of movements.
To statistically compare the groups concerning this
synchronization/desynchronization pattern in the 8–12 Hz
(corresponding to mu band) and 20–26 Hz range (the peak
of beta range, corresponding to the desynchronization peak
matching the motor pattern, see above), we computed the
power for the specific frequency of the task per subject. We
did not find statistical differences in the power between
groups across any of these motor pacing frequencies.
fMRI results
Our analysis only identified differences between healthy
controls and patients with NF1 at 5 Hz, as presented in
Fig. 5 (t(76) > 3.26, p < 0.05, multiple comparison FDR
corrected, minimum cluster size of 20 voxels). The con-
trol group presented a higher recruitment of the puta-
men, cerebellum (anterior lobe), red nucleus, medial
prefrontal cortex and auditory cortex, bilaterally. The left
superior parietal lobule showed higher activation in the
group of patients with NF1 than controls. All findings
are detailed in Table 1.
Discussion
In the present study, we aimed to understand the neural
basis of rhythmic motor pacing deficits in NF1, using a
comprehensive set of approaches, including behavioural
assessment, EEG and fMRI. We studied a cohort of
participants with NF1 and healthy controls during a sim-
ple motor task requiring pacing at distinct frequencies
during EEG recording and fMRI scans.
We found that NF1 patients were significantly impaired
in the behavioural precision of rhythmic pacing. Their
tapping times showed larger dispersion and therefore
decreased power at the cued pacing frequency. Time-
frequency analysis revealed similar oscillatory patterns
across groups that mirrored motor behaviour. Accord-
ingly, the power at the beta sub-band matched the motor
Fig. 3 Sensitivity and specificity analysis of the power at the expected frequency of tapping. ROC curves were computed for both synchronous
and alternating conditions at every frequency of finger tapping (1, 3 and 5 Hz). The best results were found for alternated tapping at 3 Hz (**),
which ROC curve showed a sensitivity of 84% and a specificity of 74%, and for the synchronous tapping at 1 Hz (*) showing a sensitivity of 74%
and a specificity of 47% to discriminate patients with NF1 from healthy controls
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behavioural patterning. BOLD signals evoked by the task
suggested group differences in the deep brain regions
pivotally involved in motor pacing, not reachable by EEG,
such as the basal ganglia and the cerebellum.
Power at the cued frequency as potentially relevant clinical
measure
The histograms of tapping times of both groups showed
clear group differences. The tapping distribution of the
healthy control group resulted in sharper curves with
higher amplitude near the ideal (cued) tapping fre-
quency. As the responses were sparser in time, the curve
of NF1 participants was broader and, consequently, the
amplitude was lower than the control group curve. The
statistical analysis of the power at the cued tapping
frequency demonstrated that performance was statisti-
cally different between groups across all frequencies in
the synchronous task and at 1 and 3 Hz in the asyn-
chronous task. ROC curve analysis showed the best dis-
crimination for alternate tapping at 3 Hz. This analysis
showed a sensitivity of 84% and a specificity of 74% to
discriminate patients with NF1 from healthy controls.
The alternate tapping variant poses larger cognitive con-
trol demands and inhibition from the contralateral
hemisphere as opposed to the synchronous tapping. Our
results suggest that the combination of 3 Hz and the
alternate variant task rendered this task more sensitive
to detect impairments in the NF1 cohort.
Impaired performance during motor tests has been
often reported in NF1 [10, 13–15, 38–41] but not in the
Fig. 4 Time-frequency plots of the control and NF1 groups during synchronous finger tapping at 1 Hz. A similarly strong periodical variation in the beta
band is conspicuous in both groups and at the ideal motor tapping frequency in the beta sub-band of 20–26 Hz, centred in the desynchronization beta
peak (23 ± 3 Hz) and with a modulation matching behaviour. Note that the colour peaks just reflect maxima and minima positions, and it is the difference
that needs to be considered for statistical analysis
Fig. 5 Significant differences between the control group and the NF1 group (t(76) > 3.26, p < 0.05, FDR corrected for multiple comparisons, minimum
cluster size of 20 voxels) during performance matched conditions (5 Hz synchronous and alternate)
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context of rhythmic pacing. Along with the motor
deficits, a wide array of impairments in other cognitive
domains is known, as executive dysfunction [3, 10, 39],
and it is believed that there is a common biological
mechanism underlying all these deficits. There is how-
ever the concern whether executive dysfunction could
underlie observed motor deficits [40, 41]. However, this
is an unlikely explanation for our results because our
groups were matched in executive function, as measured
by a Stroop task. Moreover, we used a task without
working memory load and no need to memorize motor
sequences.
Studies on mouse models suggest that abnormal neu-
rodevelopmental mechanisms in NF1 can result from an
imbalance on the excitatory and the inhibitory drive [16,
18, 22], and this may also be the case for the observed
changes in rhythmic motor pacing.
Cyclic pattern of behavioural and EEG power curves
The time-frequency analysis of the signal over the
sensorimotor cortex showed a strong periodical vari-
ation in the beta band, which closely matches the
behavioural data. This is a well-established spectral
pattern (including also the so-called post-movement
beta rebound); beta oscillations over the motor cortex
showed increased desynchronization at the beginning
of a movement and increased synchronization after
the movement (~ 300 to 1000 ms) [42]. Therefore, a
rhythmic finger-tapping task was expected to produce
a synchronization/desynchronization cyclic pattern in
the beta band with the same frequency as the tapping
movement.
A relation between beta oscillations and inhibitory ac-
tivity was demonstrated before by Gaetz and colleagues.
They found that the level of GABA, an inhibitory neuro-
transmitter, in the motor cortex correlated with the
power of the post-movement beta transient increase
[27]. Jensen and co-workers further found that benzodi-
azepines, which are GABAergic agonists, modulate beta
sources by increasing the power of the beta oscillations
at rest over the primary sensorimotor cortex [28]. Mod-
ulations in beta oscillations are linked to the behaviour
of inhibitory interneurons and thus have been related to
the underlying excitation/inhibition balance [42, 43]. Fu-
ture work should further test whether this putative link
between GABA and abnormal beta activity is suggestive
Table 1 Regions differentially recruited by the control group and the NF1 group (t(76) > 3.26, p < 0.05, FDR corrected for multiple
comparisons, minimum cluster size of 20 voxels) during the fastest tapping conditions (5 Hz synchronous and 5 Hz alternate tapping).
The clusters are described by their hemisphere (H), peak voxel coordinates in Talairach space, the t and p values in the peak voxel and
the number of voxels (n)
Peak
Region H x y z t p n
Putamen R 30 − 13 7 4.30 0.000027 33
Putamen L − 30 − 10 14 3.93 0.000119 25
Cerebellum R 15 − 40 − 26 4.02 0.000084 39
Cerebellum R,L 0 − 52 − 26 3.90 0.000135 40
Red nucleus R,L 9 − 19 − 2 4.75 0.000004 55
Medial prefrontal cortex R, L − 3 50 4 5.16 0.000001 223
Medial frontal gyrus L − 9 29 31 4.24 0.000035 92
Middle frontal gyrus L − 24 17 43 4.58 0.000008 28
Middle frontal gyrus L − 43 50 7 4.35 0.000022 47
Posterior cingulate gyrus L − 9 − 49 32 3.71 0.000275 26
Auditory cortex R 51 − 28 16 5.16 0.000001 75
Auditory cortex L − 42 − 28 19 5.80 < 0.000001 57
Superior temporal gyrus R 57 − 10 1 5.34 < 0.000001 36
Superior temporal gyrus L − 57 − 43 − 8 4.44 0.000015 92
Middle temporal gyrus L − 60 − 22 − 20 5.43 < 0.000001 217
Parahippocampal gyrus L − 27 5 − 26 4.46 0.000014 54
Precentral gyrus R 15 − 28 67 5.88 < 0.000001 26
Superior parietal lobule L − 30 − 58 43 − 4.57 0.000009 50
White matter R 24 − 46 15 − 4.62 0.000007 39
White matter L − 27 20 25 4.17 0.000047 33
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of impaired cortical inhibition and can be related to the
behavioural impairments we found here.
A critical role for regions involved in motor pacing: the basal
ganglia and cerebellum
Functional neuroimaging data analysis showed group
differences at the fastest frequency (5 Hz). This pacing
rhythm was previously demonstrated to best discrimin-
ate between healthy participants and patients with
genetic disorders leading to cerebellar atrophy and im-
paired rhythmic motor control [26]. Here, the group
contrast revealed higher recruitment of subcortical
structures of the extrapyramidal motor system in the
control group, namely the putamen, cerebellum and red
nucleus. The synchronization between the audio pacing
stimuli and the motor action requires complex informa-
tion processing involving diverse functions such as tim-
ing, temporal prediction, sequence processing and
sensory-motor integration [44]. This implies the recruit-
ment of a wide network involving the primary auditory
cortex, motor cortex, basal ganglia and cerebellar cir-
cuits. The putamen, as part of basal ganglia, plays an im-
portant role in motor control [45], and it is known to be
parametrically modulated by movement frequency [46].
The red nucleus is a pivotal region in motor function
and shows significant functional connectivity with the
cerebellum [47]. It is also generally accepted that the
cerebellum plays a role in rhythmic synchronization, by
processing timing information, as required by the
present task [44, 48]. In the cerebellum, inhibitory inter-
neurons are essential regulators of motor coordination
[49]. The pattern of differences found in the cerebellum,
a structure which is dominated by inhibitory physiology,
is consistent with the inhibitory/excitatory imbalance
theory in NF1. The task required the participant to keep
continuous monitoring of his/her own motor pacing
performance, which may explain the activation of the
dorsolateral prefrontal regions. As the level of motor de-
mand increases, the effort required to perform the task
also increases. It is known that there is an increase in
prefrontal cortex activity with the increasing of the cog-
nitive control demands [50] that is intrinsically related
to the role of PFC in monitoring and top-down control
[51]. This may explain the observed differential activa-
tion in fronto-striatal networks in our study.
The group differences identified for the auditory cor-
tex and superior parietal lobe are quite intriguing. Sen-
sorimotor synchronization implies pacing and time
prediction. As our motor paradigm is audio paced, this
process starts with the sensory input and with atten-
tional deployment in parietal cortex. This suggests that
sensorimotor integration and synchronization are also
impaired in NF1.
Conclusions
In the present study, we aimed to investigate the neural
basis of putative rhythmic motor pacing deficits in NF1
by comprehensively exploring behavioural motor con-
trol, brain rhythms and brain activity in neurofibroma-
tosis type 1.
Our study demonstrates impaired precision in rhythmic
pacing behaviour and sheds light into the neural under-
pinnings of motor timing deficits in NF1, in particular
concerning the basal ganglia and the cerebellum.
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